Catalyst Pharmaceuticals Files 8-K: Director Changes & Officer Compensation
Ticker: CPRX · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 8-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-compensation, director-changes
Related Tickers: CPRX
TL;DR
Catalyst Pharma 8-K: Director shuffle and pay changes filed Aug 4.
AI Summary
Catalyst Pharmaceuticals, Inc. filed an 8-K on August 4, 2025, reporting on the departure of a director, election of a new director, and changes in compensatory arrangements for certain officers. The filing also includes financial statements and exhibits, with the earliest event reported as August 1, 2025.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation matters, not significant financial or operational events.
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Registrant
- August 1, 2025 (date) — Earliest event reported
- August 4, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
FAQ
Who departed from the board of directors?
The filing indicates the departure of a director, but the specific name is not detailed in the provided text.
Who was elected to the board of directors?
The filing states that a director was elected, but the specific name is not provided in the excerpt.
What is the primary business of Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. is in the business of Pharmaceutical Preparations, SIC code 2834.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on August 1, 2025.
What is the fiscal year end for Catalyst Pharmaceuticals, Inc.?
The fiscal year end for Catalyst Pharmaceuticals, Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).